The value of serial plasma nuclear and mitochondrial DNA levels in patients with acute ischemic stroke

Clinica Chimica Acta

Volumn 412, Issue 5-6, 2011, Pages 476-479

  Tsai, Nai Wen ^a   Lin, Tsu Kung ^a   Chen, Shang Der ^a   Chang, Wen Neng ^a   Wang, Hung Chen ^a   Yang, Tzu Ming ^a   Lin, Yu Jun ^a   Jan, Chung Ren ^b   Huang, Chi Ren ^a   Liou, Chia Wei ^a   Lu, Cheng Hsien ^a,c  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Ischemic stroke; Mitochondrial DNA; Nuclear DNA; Plasma; Severity

Indexed keywords

CELL NUCLEUS DNA; CHOLESTEROL; HEMOGLOBIN A1C; MITOCHONDRIAL DNA; TRIACYLGLYCEROL;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BLOOD SAMPLING; BRAIN INFARCTION; BRAIN ISCHEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE SEVERITY; DYSLIPIDEMIA; ERYTHROCYTE COUNT; FEMALE; HUMAN; HYPERTENSION; LEUKOCYTE COUNT; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CELL NUCLEOLUS; DNA, MITOCHONDRIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; STROKE; YOUNG ADULT;

EID: 78650868368     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.11.036     Document Type: Article

References (31)

1. Lipton P. Ischemic cell death in brain neurons. Physiol Rev 1999, 79:1431-1568.
2. Dirnagl U., Iadecola C., Moskowitz M.A. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999, 22:391-397.
3. Rainer T.H., Wong L.K., Lam W., et al. Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke. Clin Chem 2003, 49:562-569.
4. Wunderlich M.T., Ebert A.D., Kratz T., Goertler M., Jost S., Herrmann M. Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage. Stroke 1999, 30:1190-1195.
5. Fournie G.J., Martres F., Pourrat J.P., Alary C., Rumeau M. Plasma DNA as cell death marker in elderly patients. Gerontology 1993, 39:215-221.
6. Fournie G.J., Courtin J.P., Laval F., et al. Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours. Cancer Lett 1995, 91:221-227.
7. Tsumita T., Iwanaga M. Fate of injected deoxyribonucleic acid in mice. Nature 1963, 198:1088-1089.
8. Wu T.L., Zhang D., Chia J.H., Tsao K.H., Sun C.F., Wu J.T. Cell-free DNA: measurement in various carcinomas and establishment of normal reference range. Clin Chim Acta 2002, 321:77-87.
9. Nawroz H., Koch W., Anker P., Stroun M., Sidransky D. Microsatellite alterations in serum DNA of head and neck cancer patients. Nat Med 1996, 2:1035-1037.
10. Martins G.A., Kawamura M.T., Carvalho Mda G. Detection of DNA in the plasma of septic patients. Ann NY Acad Sci 2000, 906:134-140.
11. Rhodes A., Wort S.J., Thomas H., Collinson P., Bennett E.D. Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients. Crit Care 2006, 10:R60.
12. Saukkonen K., Lakkisto P., Varpula M., et al. Association of cell-free plasma DNA with hospital mortality and organ dysfunction in intensive care unit patients. Intensive Care Med 2007, 33:1624-1627.
13. Antonatos D., Patsilinakos S., Spanodimos S., Korkonikitas P., Tsigas D. Cell-free DNA levels as a prognostic marker in acute myocardial infarction. Ann NY Acad Sci 2006, 1075:278-281.
14. Chang C.P., Chia R.H., Wu T.L., Tsao K.C., Sun C.F., Wu J.T. Elevated cell-free serum DNA detected in patients with myocardial infarction. Clin Chim Acta 2003, 327:95-101.
15. Lu C.H., Chang W.N., Tsai N.W., Chuang Y.C., Huang C.R., Wang H.C. The value of serial plasma nuclear and mitochondrial DNA levels in adult community-acquired bacterial meningitis. QJM 2010, 103:169-175.
16. Lo Y.M., Rainer T.H., Chan L.Y., Hjelm N.M., Cocks R.A. Plasma DNA as a prognostic marker in trauma patients. Clin Chem 2000, 46:319-323.
17. Lam N.Y., Rainer T.H., Chan L.Y., Joynt G.M., Lo Y.M. Time course of early and late changes in plasma DNA in trauma patients. Clin Chem 2003, 49:1286-1291.
18. Lam N.Y., Rainer T.H., Wong L.K., Lam W., Lo Y.M. Plasma DNA as a prognostic marker for stroke patients with negative neuroimaging within the first 24h of symptom onset. Resuscitation 2006, 68:71-78.
19. Goldstein L.B., Adams R., Alberts M.J., et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke 2006, 37:1583-1633.
20. Adams H.P., Bendixen B.H., Kappelle L.J., et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993, 24:35-41.
21. Sacco R.L., Adams R., Albers G., et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 2006, 37:577-617.
22. Sulter G., Steen C., De Keyser J. Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke 1999, 30:1538-1541.
23. Chiu R.W., Chan L.Y., Lam N.Y., et al. Quantitative analysis of circulating mitochondrial DNA in plasma. Clin Chem 2003, 49:719-726.
24. Lo Y.M., Tein M.S., Lau T.K., et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998, 62:768-775.
25. Butt A.N., Swaminathan R. Overview of circulating nucleic acids in plasma/serum. Ann NY Acad Sci 2008, 1137:236-242.
26. Rainer T.H., Lam N.Y., Man C.Y., Chiu R.W., Woo K.S., Lo Y.M. Plasma beta-globin DNA as a prognostic marker in chest pain patients. Clin Chim Acta 2006, 368:110-113.
27. Tsai N.W., Chang W.N., Shaw C.F., et al. The value of leukocyte adhesion molecules in patients after ischemic stroke. J Neurol 2009, 256:1296-1302.
28. Samson Y., Lapergue B., Hosseini H. Inflammation and ischaemic stroke: current status and future perspectives. Rev Neurol (Paris) 2005, 161:1177-1182.
29. Huang J., Upadhyay U.M., Tamargo R.J. Inflammation in stroke and focal cerebral ischemia. Surg Neurol 2006, 66:232-245.
30. Jiang N., Pisetsky D.S. The effect of inflammation on the generation of plasma DNA from dead and dying cells in the peritoneum. J Leukoc Biol 2005, 77:296-302.
31. Rainer T.H., Lam N.Y. Circulating nucleic acids and critical illness. Ann NY Acad Sci 2006, 1075:271-277.